(HealthDay)—People with adult-onset congenital heart disease of lesser complexity have a higher burden of adverse cardiovascular events than the general population, independent of conventional cardiovascular risk factors, according to a study published Feb. 28 in Traffic. Priyanka Saha of Stanford University School of Medicine in California and colleagues attempted toRead More →

A new market study, titled “Global Valvular Heart Diseases Treatment Market Research and Forecast, 2018-2023” was featured on WiseGuyReports. Valvular heart disease characterized by a defect or damage in one of the four heart valves, namely mitral, aortic, tricuspid or pulmonary. Adult heart surgery such as the treatment of valvularRead More →